GlassScriptPhysician profile
Tejal Jetha
NPI 1134384613
$545.61
in general payments reported to CMS, 2019-2025
7 companies · $117 in 2025
The $117 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $123 · 2021: $63.10 · 2022: $131 · 2023: $22.51 · 2024: $89.32 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $229.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $217.28 | 2020-2024 | Xarelto |
| Pfizer INC. | $126.93 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $78.80 | 2020-2025 | Zerbaxa, Dificid |
| E.R. Squibb & Sons, L.L.C. | $54.68 | 2022 | |
| Novartis Pharmaceuticals Corporation | $30.90 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.72 | 2022 | |
| Chiesi USA, INC. | $17.30 | 2025 | Cleviprex, Kengreal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tejal Jetha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.